Search Results 851-860 of 19264 for hemoglobin
duration of the study and 30 days following the last dose of study drug. Exclusion Criteria: - Subject has severe anemia defined as hemoglobin <8.0 g/dL (<4.9 ...
... hemoglobin <10 milligrans/ deciliters (mg/dL)} 3. Stable kidney function with no known episodes of AKI within 2 weeks of screening. Exclusion Criteria: 1 ...
Hemoglobin ≥ 8.0 g/dl: The use of transfusion or other intervention to achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable. For females of child-bearing ...
Hemoglobin ≥ 10 g/dL. Patient must have the ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria.
ECOG Performance Status grade of 0 or 1. Clinical laboratory values meeting the following criteria during the Screening Phase: HEMOTOLOGY. Hemoglobin. ≥ 8.0 ...
Baseline hemoglobin < 8.5 g/dl, aspartate aminotransferase (AST) or alanine aminotransferase (ALT) that is five times or more the upper limit of normal or ...
Hemoglobin ≥ 10 g/dL;; Total bilirubin ≤ 1.5 x upper limit of normal (ULN), unless due to Gilbert's disease;; Aspartate transaminase (AST/SGOT) and alanine ...
Normal hemoglobin >11.0 g/dL for women and men will be acceptable. Women of child-bearing potential will complete a urine pregnancy test at each visit.
A lack of folate and vitamin B-12 can cause red blood cells to become too large so they can't carry oxygen well.
The purpose of this study is to test if a reduction of hemoglobin leads to subclinical cardiac dysfunction in patients with known cardiovascular disease. .
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.